Views & Analysis | Perspectives on pharma industry issues

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Market Access

Sponsored

The pre-commercial case for connecting data before acquiring...

For EBPs, launch requires a data strategy that starts with agreement on the KPIs, and those depend on the therapeutic areas.

Articles

The NHS in 2013: the new leaders of healthcare – who are the...

Anthony Rowbottom discusses the introduction of the Health and Social Care Act 2012, which is set to transform the healthcare landscape from April 2013. A lot has been written about David Bennett, most notably his connections to McKinsey. Indeed, critics of the...

Articles

Increasing adherence with patient support

To start our patients focus month, pharmaphorum speaks with Zoe Barker speaks on how supporting patients can increase medication adherence. Non-compliance can be a huge obstacle to achieving effective health care. The World Health Organization estimated in...

Articles

Doctors' views on pharma: part five

As our medical communication focus month comes to an end, we speak with our fifth and final doctor to gain his perspective of communication within the pharma industry. To coincide with our medical communications focus month, pharmaphorum speaks with five healthcare professionals to...

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital